Background. Cytokines, interleukin (IL)-4, IL-6, interferon-gamma (IFN
-alpha), tumor necrosis factor-alpha (TNF-gamma), soluble CD23 (sCD23)
, and soluble IL-2 receptors (sIL-2R) are mediators of inflammation an
d immune response. Alterations in immune status of patients with vario
us cancers may result in release of cytokines in circulation. The auth
ors measured the circulating levels of IL-4, IL-6, IFN-gamma, TNF-alph
a, sCD23, and sIL-2R from patients with T-cell chronic lymphocytic leu
kemia (T-CLL), T-cell acute lymphoblastic leukemia (T-ALL) and periphe
ral T-cell lymphoma (PTCL) to determine their importance in these T-ce
ll disorders. Methods. IL-4, IL-6, IFN-gamma, TNF-alpha, sCD23, and sI
L-2R levels were measured from the serum samples by enzyme-linked immu
nosorbent assay or bioassay methods. Results. IL-4 levels were higher
only in T-CLL, whereas, IFN-gamma and sIL-2R levels were higher in T-C
LL and T-ALL. However, IL-6, TNF-alpha, and sCD23 levels were higher i
n PTCL. Conclusions. T-cell-derived IL-4 and IFN-gamma in T-CLL may ac
t as an autocrine growth factor for proliferation of neoplastic T-cell
s. The sIL-2R levels in T-CLL, T-ALL, and PTCL are an indication of th
e degree of T-cell or immune activation due to concomitant immunologic
processes in these disorders. However, IL-6, TNF-alpha, and sCD23 lev
els may contribute to inflammatory response and provide evidence of mo
nocyte/macrophage, T-cell, or B-cell aberrations in PTCL.